Advanced search
Publication Cover
Psychology, Health & Medicine Volume 23, 2018 - Issue 1
Submit an article Journal homepage
209
Views
4
CrossRef citations to date
0
Altmetric
Articles

Patient preferences for medicine administration for acute agitation: results from an internet-based survey of patients diagnosed with bipolar disorder or schizophrenia in two Nordic countries

Tine Rikke JørgensenJanssen-Cilag, Birkerød, DenmarkCorrespondence[email protected]
,
Charlotte EmborgDepartment of Clinical Medicine – The Department of General Psyciatry, Aarhus University, Risskov, Denmark
,
Karianne DahlenMedivir AB, Stockholm, Sweden
,
Mette BøgelundIncentive, Holte, DenmarkORCID Iconhttp://orcid.org/0000-0003-0866-9414
ORCID Icon &
Andreas CarlborgDepartment of Clinical Neuroscience, Centre for Psychiatric Research and Education, Karolinska Institutet, Stockholm, SwedenORCID Iconhttp://orcid.org/0000-0001-9719-3045
ORCID Icon
Pages 30-38 | Received 29 Aug 2016, Accepted 19 Apr 2017, Published online: 05 May 2017

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Justin Faden, Joseph F Goldberg & Leslie Citrome. (2023) Improving the pharmacotherapeutic treatment of agitation associated with bipolar disorder. Expert Opinion on Pharmacotherapy 24:16, pages 1811-1822.
Read now

Articles from other publishers (3)

Rachel E. Walker, Leigh Anne Nelson, Carrie Kriz, Courtney A. Iuppa, Yifei Liu, Lauren A. Diefenderfer, Ellie S. R. Elliott & Roger W. Sommi. (2022) Enhancing Outcomes: Acceptability of Medication Formulations for the Treatment of Acute Agitation in a Psychiatric Population. Pharmacy 11:1, pages 4.
Crossref
Yuqing Ye, Ying Ma & Jesse Zhu. (2022) The future of dry powder inhaled therapy: Promising or discouraging for systemic disorders?. International Journal of Pharmaceutics 614, pages 121457.
Crossref
Bruno Pacciardi, Alfredo Calcedo & Thomas Messer. (2019) Inhaled Loxapine for the Management of Acute Agitation in Bipolar Disorder and Schizophrenia: Expert Review and Commentary in an Era of Change. Drugs in R&D 19:1, pages 15-25.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.